AnalystsDennis DingDennis Ding's Stock Forecasts
AnalystsDennis Ding
Sectors:
Analyst Ranking
Bottom 7%
#4662 out of 4986 analysts
Average Return
-27.91%
Win Rate
29%4 out of 14
Risk vs Reward
Poor
Good
Dennis Ding's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cincor Pharma IncCINC | +52.26% | $19.00 | $28.93 | 2022-01-31 - 2023-01-31 | Strong Buy |
Indivior PLCINDV | +45.12% | $16.18 | $23.48 | 2025-07-21 - 2025-08-19 | Strong Buy |
Assembly Biosciences IncASMB | +29.80% | $19.43 | $25.22 | 2024-09-19 - 2025-08-19 | Strong Buy |
Arbutus Biopharma CorpABUS | +0.35% | $2.89 | $2.90 | 2022-02-01 - 2023-02-01 | Strong Buy |
Dennis Ding Analyst Color
Get additional color on Dennis Ding's coverage of popular stocks
Dennis Ding's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Indivior PLCINDV | 1 | Strong Buy | $20.00 | -14.82% | Assumes | a month ago |
Mineralys Therapeutics IncMLYS | 1 | Hold | $15.00 | +3.66% | Initiates Coverage On | 2 months ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $55.00 | +86.88% | Upgrades | 7 months ago |
Inhibikase Therapeutics IncIKT | 1 | Strong Buy | $8.00 | +370.59% | Initiates Coverage On | 9 months ago |
Assembly Biosciences IncASMB | 1 | Strong Buy | $35.00 | +38.78% | Upgrades | a year ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $18.00 | +145.23% | Initiates Coverage On | a year ago |
Arbutus Biopharma CorpABUS | 2 | Strong Buy | $7.00 | +100.57% | Maintains | a year ago |
Recursion Pharmaceuticals IncRXRX | 1 | Hold | $6.00 | +17.88% | Maintains | a year ago |
Lyra Therapeutics IncLYRA | 1 | Hold | $25.00 | N/A | Downgrades | a year ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $216.00 | N/A | Reiterates | 2 years ago |
Corcept Therapeutics IncCORT | 1 | Hold | $22.00 | N/A | Downgrades | 3 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cincor Pharma IncCINC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Pardes Biosciences IncPRDS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Sigilon Therapeutics IncSGTX | 2 | Hold | $52.00 | N/A | Downgrades | 4 years ago |
Roivant Sciences LtdROIV | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.